Allianz Agrees to Buy HSBC Life Singapore for S$2.7 Billion With a 15-Year Exclusive Bancassurance Deal, Beating Sumitomo Life and Daiichi Life

German insurer Allianz has won the contest for HSBC's life and health insurance business in Singapore. Insurance Business reported on July 24, 2026 that Allianz Asia Holdings is acquiring HSBC Life (Singapore) outright from HSBC Insurance (Asia-Pacific) Holdings for S$2.7 billion, equivalent to about US$2.1 billion or £1.6 billion. The announcement settles what earlier press reports had described as a race in which Allianz was the frontrunner and in which HSBC was reported to be seeking a valuation of up to about US$2 billion.

The agreement has two parts. The first is the purchase of the company. The second is a 15-year exclusive bancassurance agreement, in which HSBC's branches will sell Allianz protection, health, retirement and wealth products to customers in Singapore. Allianz is paying an upfront S$200 million for the distribution rights. Bancassurance is the practice of selling insurance through a bank's customer network, and for an insurer it can be more valuable than the policies already on the books because it provides access to a stream of new customers. A long exclusive contract is meant to protect that stream.

Completion is expected in the first half of 2027 and depends on approval by the Monetary Authority of Singapore (MAS). That timetable means HSBC Life will continue to operate under HSBC ownership for several more months, and customers will not see changes to their policies on the announcement date. Existing policies would normally continue on the same terms after an ownership change.

For HSBC, the sale is a financial and strategic step. The bank expects a pre-tax gain of roughly US$1.8 billion and a boost to its core capital ratio of up to 15 basis points, which is 0.15 percentage points. HSBC Life Singapore posted a pre-tax profit of S$118 million for 2025. HSBC's London-listed shares rose by more than 1% after the news, while Allianz shares moved only marginally in early trading. HSBC is not leaving insurance distribution: its branches will continue to sell Allianz products under the new agreement.

For Allianz, the deal is a significant expansion in a market it has tried to enter on a larger scale before. In 2024, the insurer walked away from a roughly S$2.2 billion bid for a majority stake in Income Insurance, formerly NTUC Income, after public criticism and government scrutiny. The HSBC target is a foreign bank's subsidiary rather than a cooperative-rooted local insurer, which may make the transaction less politically sensitive, although the article does not say so. Allianz says it has a regional presence of roughly a century, operates in eight Asian markets and has around 9 million customers, and the acquisition makes Singapore one of its largest life and health markets in Asia. Chief executive Oliver Bäte called Singapore "central to our global growth strategy", and board member Renate Wagner said the deal aims "to support more individuals and communities even more comprehensively."

Competition was real. Insurance Business says Sumitomo Life and Daiichi Life were reported as rivals, and that in mid-June it had reported Allianz outbidding them for a business then valued at up to US$2 billion. The article does not give the rivals' bid amounts. A later Insurance Business report, on October 16, noted that Allianz beat Sumitomo Life to HSBC's Singapore life business, and that Sumitomo Life is looking for deals in the United States and Southeast Asia, naming Income Insurance as a possible target.

The market backdrop is positive. Bloomberg Intelligence analyst Steven Lam expects Singapore's life insurance new business to grow at least 15% this year, according to the article. Rising incomes, an ageing population and high savings rates make life, health and retirement products attractive. That growth, together with the profit figure of S$118 million for HSBC Life, helps explain the price. At S$2.7 billion, it is about 23 times the 2025 pre-tax profit, although part of the price is for the exclusive 15-year distribution agreement and not just for the profits of the existing business, so a simple multiple overstates what is paid for earnings alone.

The article does not state premium volumes or customer numbers for HSBC Life Singapore, so it is not possible to describe the size of the book beyond its profit. Nor does it describe how the S$2.7 billion will be financed.

What should readers watch? The MAS approval is the main milestone. Integration will matter for customers and staff, particularly how Allianz handles the move from HSBC's brand and systems, and how well HSBC's sales force adapts to selling a partner's products under an exclusive arrangement. In the wider market, the deal signals that bancassurance contracts remain highly valued, and that foreign insurers are willing to pay high prices to secure distribution in Singapore. It also underlines the position of Singapore as a hub where global insurers want a presence, as the Monetary Authority's work on new risk-transfer structures such as protected cell companies suggests.